Publications by authors named "O Pfaar"

Claim this Profile
E
Evaluation of the Quality and Reliability of ChatGPT-4's Responses on Allergen Immunotherapy Using Validated Instruments for Health Information Quality Assessment.
Ivan Cherrez-Ojeda, Torsten Zuberbier, Gabriela Rodas-Valero, Jorge Sanchez, Michael Rudenko, Oliver Pfaar

Clin Transl Allergy· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Allergic Rhinitis and Its Impact on Asthma (ARIA)-EAACI Guidelines-2024-2025 Revision: Part I-Guidelines on Intranasal Treatments.
Bernardo Sousa-Pinto, Jean Bousquet, Rafael José Vieira, Holger J Schünemann, Torsten Zuberbier, Oliver Pfaar

Allergy· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Efficacy of One Short Course of Mannan-Conjugated Birch Pollen Allergoid Immunotherapy: A Comparative Evaluation After Prior Placebo Treatment.
Sandra Del Pozo, Natascha Wahrhusen, Oliver Pfaar, Esther Raskopf, Anna Rybachuk

J Clin Med· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Systematic Review and Meta-Analysis on the Induction of Confirmed Eosinophilic Esophagitis as a Side Effect of Allergen Immunotherapy: An EAACI Task Force Report.
Carlo Maria Rossi, Ingrid Terreehorst, Evaggelia Apostolidou, Martina Votto, Arzu Bakirtas, Oliver Pfaar

Allergy· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Different immunological types of CRSwNP in the context of the new European EAACI nomenclature : Part 2: Hypersensitivity reactions of type V (epithelial barrier defects)].
L Klimek, S Becker, B Haxel, M Cuevas, P Huber, O Pfaar

HNO· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis